According to new market intelligence from Intel Market Research, the global ADHD medications market reached USD 769 million in 2024 and is projected to expand to USD 1.41 billion by 2034, growing at an impressive CAGR of 9.3% through the forecast period. This substantial growth reflects evolving treatment paradigms and increasing recognition of ADHD across age groups globally.
Understanding...
According to a new report from Intel Market Research, the global Attention-Deficit Hyperactivity Disorder (ADHD) Medications market was valued at USD 12,090 million in 2024 and is projected to reach USD 17,430 million by 2032, growing at a steady CAGR of 5.3% during the forecast period (2025-2032). This growth trajectory reflects increasing global awareness of neurodevelopmental disorders,...
The medical landscape is currently experiencing a transformative phase in the management of parasitic infections, significantly impacting the Ivermectin Medication Market Growth. This market is anticipated to expand at a CAGR of 8.6% from 2026 to 2034, reaching new heights in both therapeutic and prophylactic applications. The sustained demand is fueled by the medication's dual utility in human...
According to the latest report published by Data Bridge Market Research, the Angina Pectoris Drugs Market
The global angina pectoris drugs market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 17.09 billion by 2033, at a CAGR of 5.50% during the forecast period
The universal Angina Pectoris Drugs Market report has...
According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market
Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030
Global market research...
Obesity Treatment Drugs and GLP-1 Receptor Agonists Driving the Anti-Obesity Medication Market Growth
The global healthcare landscape is witnessing a significant transformation with the rapid advancement of obesity treatment drugs, weight loss medications, and next-generation GLP-1 receptor agonists. Rising obesity prevalence, sedentary lifestyles, and metabolic disorders have positioned...
The global antidiabetics market is witnessing substantial growth due to the increasing prevalence of diabetes, growing awareness regarding disease management, and continuous advancements in pharmaceutical therapies. Diabetes has emerged as one of the most significant public health challenges worldwide, creating a strong demand for effective treatment solutions that help manage blood glucose...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek